Takada, E.; Nakamura, N.; Kaneda, Y.; Fukuno, K.; Lee, S.; Fujita, K.; Morishita, T.; Ikoma, Y.; Matsumoto, T.; Nakamura, H.;
et al. Impact of Skeletal Muscle Depletion on Patients with Myelodysplastic Syndrome Treated with Azacitidine. Hematol. Rep. 2024, 16, 114-124.
https://doi.org/10.3390/hematolrep16010012
AMA Style
Takada E, Nakamura N, Kaneda Y, Fukuno K, Lee S, Fujita K, Morishita T, Ikoma Y, Matsumoto T, Nakamura H,
et al. Impact of Skeletal Muscle Depletion on Patients with Myelodysplastic Syndrome Treated with Azacitidine. Hematology Reports. 2024; 16(1):114-124.
https://doi.org/10.3390/hematolrep16010012
Chicago/Turabian Style
Takada, Eri, Nobuhiko Nakamura, Yuto Kaneda, Kenji Fukuno, Shin Lee, Kei Fujita, Tetsuji Morishita, Yoshikazu Ikoma, Takuro Matsumoto, Hiroshi Nakamura,
and et al. 2024. "Impact of Skeletal Muscle Depletion on Patients with Myelodysplastic Syndrome Treated with Azacitidine" Hematology Reports 16, no. 1: 114-124.
https://doi.org/10.3390/hematolrep16010012
APA Style
Takada, E., Nakamura, N., Kaneda, Y., Fukuno, K., Lee, S., Fujita, K., Morishita, T., Ikoma, Y., Matsumoto, T., Nakamura, H., Kitagawa, J., Kanemura, N., Kasahara, S., Hara, T., Tsurumi, H., & Shimizu, M.
(2024). Impact of Skeletal Muscle Depletion on Patients with Myelodysplastic Syndrome Treated with Azacitidine. Hematology Reports, 16(1), 114-124.
https://doi.org/10.3390/hematolrep16010012
